PWMG
NVAX icon

Prestige Wealth Management Group’s Novavax NVAX Stock Holding History

Prestige Wealth Management Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29
Closed -$195 – 1154
2025
Q4 		$195 Hold
29
– – ﹤0.01% 991
2025
Q3 		$252 Hold
29
– – ﹤0.01% 975
2025
Q2 		$183 Hold
29
– – ﹤0.01% 985
2025
Q1 		$186 Hold
29
– – ﹤0.01% 987
2024
Q4 		$234 Hold
29
– – ﹤0.01% 1014
2024
Q3 		$367 Hold
29
– – ﹤0.01% 994
2024
Q2 		$368 Hold
29
– – ﹤0.01% 951
2024
Q1 		$139 Hold
29
– – ﹤0.01% 1005
2023
Q4 		$140 Hold
29
– – ﹤0.01% 1005
2023
Q3 		$210 Hold
29
– – ﹤0.01% 1028
2023
Q2 		$216 Hold
29
– – ﹤0.01% 1037
2023
Q1 		$201 Hold
29
– – ﹤0.01% 1035
2022
Q4 		$298 Sell
29
-5
-15% -$88 ﹤0.01% 1119
2022
Q3 		$1K Sell
34
-15
-31% -$650 ﹤0.01% 883
2022
Q2 		$3K Buy
49
+20
+69% +$1.04K ﹤0.01% 700
2022
Q1 		$2K Buy
29
+12
+71% +$1.07K ﹤0.01% 788
2021
Q4 		$2K Buy
17
+2
+13% +$344 ﹤0.01% 812
2021
Q3 		$3K Sell
15
-5
-25% -$1.1K ﹤0.01% 743
2021
Q2 		$4K Buy
+20
New +$3.66K ﹤0.01% 685

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prestige Wealth Management Group's NVAX Position: Q1 2026 in Review

Prestige Wealth Management Group sold out of Novavax (NVAX) in Q1 2026, closing a stake of 29 shares — an estimated $195 sold.

Prestige Wealth Management Group first reported a position in NVAX in Q2 2021 and held it in 19 quarters. The position peaked at $4K in Q2 2021. 259 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Prestige Wealth Management Group reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
  • Prestige Wealth Management Group sold 29 Novavax shares in Q1 2026, an estimated $195.
  • Prestige Wealth Management Group first reported a position in Novavax in Q2 2021 and held it in 19 quarters.
  • Prestige Wealth Management Group's Novavax position peaked at $4K in Q2 2021.
  • 259 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Prestige Wealth Management Group's 13F filing for Q1 2026, filed 13 May 2026.